Surgery News and Research

RSS

Columbia University Medical Center performs the 100th ATS 3f Aortic Bioprosthesis implant

ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that Columbia University Medical Center has achieved 100 implants of the ATS 3f(R) Aortic Bioprosthesis. Based on the precept that 'Form Follows Function,' the ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless pericardial aortic tissue valve that is unlike any other valve.

21 Sep 2009

UltraPulse SurgiTouch CO2 laser for the treatment of airway stenosis

Lumenis Ltd., the world's largest medical laser company, announced today that it supplied an UltraPulse SurgiTouch CO2 laser with Digital AcuBlade microsurgery system to the Landspitalinn University Hospital in Reykjavik, Iceland. Lumenis' state of the art laser system, was used by Dr. Paul Castellanos to perform Trans-oral Laser Microsurgery (TLM) for the treatment of airway stenosis with obstructing neurofibromatosis of the laryngopharynx on a 9-year-old girl and four other patients.

From Lumenis Inc. 21 Sep 2009

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).

21 Sep 2009

Clothes for women who undergo a mastectomy

One in eight U.S. women will be diagnosed with breast cancer during their lifetime, and currently slightly more than half, 56 percent, undergo mastectomy. Few fashion options exist for those who don’t seek reconstructive surgery or postpone it until after their treatment and recovery — a condition the clothier Wear Ease (www.WearEase.com) seeks to remedy.

21 Sep 2009

GI cancer detection simpler and cost-effective with new blood tests

Berlin, Germany: Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], in Berlin today (Monday September 21). The tests will make GI cancer detection simpler, cost-effective, and more acceptable to patients than current methods, the researchers say.

21 Sep 2009

AFib ablated using visually-guided laser balloon catheter

Physicians at The Mount Sinai Medical Center in New York became the first in the U.S. to ablate atrial fibrillation using a visually-guided laser balloon catheter.

21 Sep 2009

CT-guided tube pericardiostomy, an effective treatment for pericardial effusion

Pericardial effusion, the collection of fluid around the heart, typically occurs in patients following heart surgery and is usually treated using an invasive surgical drainage technique. However researchers have discovered that a minimally invasive procedure called CT-guided tube pericardiostomy is just as effective - requiring no recovery time, fewer resources, and provides an 89 percent cost savings over the surgical drainage technique, according to a study published in the October issue of the American Journal of Roentgenology (AJR).

21 Sep 2009

New interferon/lovastatin treatment to battle cancer

For selected patients, he decided he might have something better. He now has opened NeoPlas Innovation in Nashville to offer the combination "off-label" treatment on an outpatient basis.

21 Sep 2009

Study reveals that GI cancer can be diagnosed using blood tests

...

21 Sep 2009

Center for Hip Pain and Preservation focuses on improved understanding of hip abnormalities

Recent improved understanding of hip abnormalities, combined with advances in diagnostic imaging techniques and minimally invasive surgical treatments are giving many patients new hope for relieving chronic, misdiagnosed hip pain.

21 Sep 2009

Doctors discuss defensive medicine and primary care pay

...

21 Sep 2009

KCI to conduct discussion on limb surgeries and amputations

Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26.

19 Sep 2009

Health Discovery Corporation appoints new COO

Health Discovery Corporation, a personalized medicine company specializing in molecular diagnostics including gene-based testing, as well as computer assisted diagnostics in digital pathology and radiology, announced that former Deputy FDA Commissioner John A. Norris has been appointed as Chief Operating Officer (COO) of the Company.

19 Sep 2009

Ethridge Plastic Surgery focuses on personalized reconstructive procedures

A Fort Worth plastic surgeon, Richard T. Ethridge, M.D., P.A., strives to promote health and well-being through a comprehensive and personalized approach to rejuvenative and reconstructive surgery. Dr. Ethridge specializes in plastic and reconstructive surgery, with a focus on cosmetic and reconstructive procedures of the breast, body, and face.

19 Sep 2009

Sight for Life Foundation offers free vision care

The CIGNA (NYSE:CI) Foundation today named Dr. Eva Liang, an ophthalmologist with the Cigna Medical Group in Phoenix, as the company’s Volunteer of the Year. Dr. Liang founded the Sight for Life Foundation in 2001 while in private practice in Las Vegas.

19 Sep 2009

Experts’ comments on America's obesity epidemic

As a recent Newsweek article states, "it's hardly clear that there actually is an obesity epidemic, or that fat people are at greater risk of death than people of normal weight, or that weight loss—relentlessly promoted by public-health officials as the solution to America's weight problem—is an attainable goal at all."

19 Sep 2009

AMR finds 75 percent of hetastarch recipients underwent surgical procedures

Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that for the January - May 2009 time period, a significantly higher percentage of hetastarch recipients (75%) underwent a surgical procedure when compared to those receiving albumin/plasma protein fraction (51%).

19 Sep 2009

Catheter for varicose vein treatment

Further results from the initial clinical trial of the ClariVein(TM) catheter, used in a new minimally invasive treatment for varicose veins, will be delivered on Friday, September 25, at the 23rd Annual Meeting of the Eastern Vascular Society in Philadelphia.

19 Sep 2009

Program to promote patients’ overall health following kidney transplant surgery

Patient adherence after a kidney transplant, or faithfully following a prescribed medical regimen, is vital to a transplant recipient's health and the survival of their new organ.

19 Sep 2009

Biopharmaceutical company announces initial public offering

Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.

18 Sep 2009